PRTODAY / NewswireToday Free press release distribution service network

More news: Energy
Written by / Agency / Source: AREVA

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Treatment Against Cancer – AREVA Launches Construction of the Maurice Tubiana Laboratory to Produce Lead-212 - AREVA launches the construction of a laboratory to produce medical quality Lead-212 at the Bessines-sur-Gartempe site in the Limousin (France) - AREVA.com
Treatment Against Cancer – AREVA Launches Construction of the Maurice Tubiana Laboratory to Produce Lead-212

 

NewswireToday - /newswire/ - Paris, France, 2011/05/31 - AREVA launches the construction of a laboratory to produce medical quality Lead-212 at the Bessines-sur-Gartempe site in the Limousin (France) - AREVA.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Energy Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

AREVA Med, an AREVA subsidiary bringing the project within the group, thus enters a key phase towards the industrial production of Lead-212, an isotope used in the development of promising treatments against cancer.

The laboratory, the only one of its kind in the world, will begin production in 2013. It will be named after Professor Maurice Tubiana, a member of the Academy of Science whose work on cancer is a worldwide reference.

Anne Lauvergeon, AREVA CEO, stated that "Constructing the Maurice Tubiana laboratory reflects AREVA’s determination to make innovative therapies for the treatment of cancers available as soon as possible to both doctors and patients. The therapeutic potential of Lead-212 extracted from spent nuclear fuel was discovered by our employees, which generates pride within the group".

The official launch of the construction of the new laboratory follows on the authorization granted to AREVA Med by the American authorities in January 2011 to begin the first clinical trials of a new treatment with Lead-212.

Innovation in nuclear medicine is related mainly to the availability of medical quality isotopes. With the Maurice Tubiana laboratory, the production of the rare Lead-212 isotope should make it possible to treat the most aggressive forms of cancer.

• AREVA press office:
Patricia Marie / Fleur Floquet-Daubigeon / Maxime Michaut

• AREVA Investors Relations:
Marie de Scorbiac
T: +33 1 34 96 05 97 / E: marie.descorbiac[.]areva.com.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Energy Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: AREVA

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Energy articles,
CATCH Visitors via Your Competitors Announcements!


Treatment Against Cancer – AREVA Launches Construction of the Maurice Tubiana Laboratory to Produce Lead-212

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

AREVA |
Publisher Contact: Press Office - AREVA.com 
+33 1 34 96 12 15 press[.]areva.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any AREVA securities in any jurisdiction including any other companies listed or named in this release.

Energy via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From AREVA / Company Profile


Read Energy Most Recent Related Newswires:

Liquefied Gas Pump Market to Record an Exponential CAGR by 2026 According to Persistence Market Research
GE and Solairedirect India Partner for the Next 25 Years
ENGIE Wins Major Contract with Transport for London
Boost in Genset Manufacturing Activity to Resolve Power Challenges in the Southern African Region Finds Frost & Sullivan
ENGIE to Become Worldwide Leader of Independent District Cooling by Acquiring A 40% Stake in Tabreed from Mubadala
Asia-Pacific Renewable Energy Inverters Market Leverages Favourable Targets and Feed-in Tariffs to Catalyze Growth, finds Frost & Sullivan
GE Introduces Rugged, Resilient Power Supply for Industrial Applications
Energy Technology Developers Focus on Sustainability and Efficiency to Stay Relevant in a Changing Market Finds Frost & Sullivan
Baker Hughes and GE Announce Executive Leadership Team for Baker Hughes, a GE Company
Enel Green Power Acquires Two Wind Farms in Campania from Amec Foster Wheeler
Enel and Rosseti Sign MoU for Cooperation in Innovative Smart Grid Solutions
World’s Largest Floating Photovoltaic Power Plant Test-bed Features ABB Technology
Enel Group Confirmed in Euronext Vigeo Eiris Sustainability Indices for Fifth Straight Year
Invenergy Selects GE Renewable Energy to Provide Cyber Security for Entire Fleet
GNF3 Fuel Product Completes U.S. NRC Approved Process for New Fuel Product Introductions

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  JobsWare.com

Visit  Persistence Market Research (P) Ltd





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)